Science and Innovation: The US Pharmaceutical Industry during the 1980s
By Alfonso Gambardella
•Publisher: Cambridge University Press
•Number Of Pages: 216
•Publication Date: 1995-03-31
•ISBN-10 / ASIN: 0521451183
•ISBN-13 / EAN: 9780521451185
By Alfonso Gambardella
•Publisher: Cambridge University Press
•Number Of Pages: 216
•Publication Date: 1995-03-31
•ISBN-10 / ASIN: 0521451183
•ISBN-13 / EAN: 9780521451185
Size: 4.57 MB
This book deals with an increasingly important phenomenon for competitiveness and innovation in industry: namely, the growing use of basic scientific principles in industrial research. It focuses on the pharmaceutical industry, and discusses how recent significant developments in molecular biology and genetic engineering are influencing the strategies of drug companies, their organization of internal research, their relationships with scientific institutions, the market structure of the industry, and the productivity of drug research.
Contents: List of figures; List of tables; Preface; List of abbreviations; 1. Introduction; 2. Science and innovation in pharmaceutical research; 3. Economic implications of greater scientific intensity in drug research; 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies; 5. Scientific research and drug discovery: an econometric investigation; 6. A model of the innovation cycle in the pharmaceutical industry; 7. Complementarity and external linkages: the strategies of large firms in biotechnology; 8. Conclusions; Notes; References; Index.
Contents: List of figures; List of tables; Preface; List of abbreviations; 1. Introduction; 2. Science and innovation in pharmaceutical research; 3. Economic implications of greater scientific intensity in drug research; 4. In-house scientific research and innovation: case studies of large US pharmaceutical companies; 5. Scientific research and drug discovery: an econometric investigation; 6. A model of the innovation cycle in the pharmaceutical industry; 7. Complementarity and external linkages: the strategies of large firms in biotechnology; 8. Conclusions; Notes; References; Index.
0 comments:
Post a Comment